Showing results (101-110 of 956) with videos related to
Sort By:
Pageof 96
Schizophrenia Research|July 14, 2007
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled studyTomiki Sumiyoshi, Sohee Park, Karu Jayathilake, et al.Journal of Psychopharmacology (Oxford, England)|September 27, 2017
Associations of fatty acids with cognition, psychopathology, and brain-derived neurotrophic factor levels in patients with first-episode schizophrenia and related disorders treated with paliperidone extended releaseYoung-Chul Chung, Yin Cui, Tomiki Sumiyoshi, et al.Journal of Affective Disorders|June 9, 2024
Loneliness and posttraumatic stress in U.S. adolescents: A longitudinal studyAndrew Stickley, Johan Isaksson, Roman Koposov, et al.Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|April 17, 2008
[Minocycline as a therapeutic drug for methamphetamine use disorders]Kenji HashimotoAdvances in Clinical Chemistry|February 27, 2018
Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future PerspectiveKenji HashimotoCurrent Pharmaceutical Design|June 6, 2015
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational BiomarkerKenji HashimotoBrain Research Reviews|June 2, 2009
Emerging role of glutamate in the pathophysiology of major depressive disorderKenji HashimotoNihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 30, 2010
[Role of sigma-1 receptors in neural plasticity and in antipsychotic action]Kenji HashimotoEuropean Archives of Psychiatry and Clinical Neuroscience|January 6, 2021
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptorKenji HashimotoCurrent Psychiatry Reports|July 7, 2019
Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical FindingsKenji HashimotoPageof 96